LesleyMussioArnoldMD
Psychiatry • Cincinnati, OHProfessor, Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine
Dr. Arnold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
260 Stetson Avenue
Psychiatry
Cincinnati, OH 45219Phone+1 513-558-7700Fax+1 513-558-0877
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1987 - 1991
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1986 - 1987
University of Cincinnati College of MedicineClass of 1986
Certifications & Licensure
OH State Medical License 1990 - 2025- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Gabapentin in Fibromyalgia Trial (GIFT) Start of enrollment: 2003 Mar 01
- Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome Start of enrollment: 2006 Sep 01
- A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome Start of enrollment: 2011 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 192 citationsA 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.Lesley M. Arnold, I. Jon Russell, E.W. Diri, W. Rachel Duan, James P. Young
The Journal of Pain. 2008-09-01 - 68 citationsFibromyalgia: management strategies for primary care providers.Lesley M. Arnold, Kevin B. Gebke, Ernest Choy
International Journal of Clinical Practice. 2016-02-01 - 40 citationsChallenges of implementing fibromyalgia treatment guidelines in current clinical practice.Lesley M. Arnold, Daniel J. Clauw
Postgraduate Medicine. 2017-06-19
Press Mentions
Nerve Stimulation Therapy Could Cut Fibromyalgia PainJanuary 16th, 2020
Aptinyx Begins Two Phase 2 Studies of NYX-2925November 12th, 2019
Gabapentin Shown Effective for Fibromyalgia PainJune 12th, 2007
Grant Support
- Development Of A Fibromyalgia Responder IndexNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
- Genetic Fibromyalgia StudyNational Center For Research Resources2004
- Controlled Family Study In Patients With FibromyalgiaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
